Jounce Therapeutics, Inc.

VANGUARD GROUP INC

Report date

3/31/2023

Quarter

2023 Q1

Filed

7/14/2023

Shares

2,107,305

Value ($000)

3,899

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	7/14/2023	3,899	0.0%	2,107,305	3/31/2023
2022 Q4	2/10/2023	1,813	0.0%	1,633,178	12/31/2022
2022 Q3	11/14/2022	3,804	0.0%	1,625,857	9/30/2022
2022 Q2	8/12/2022	4,857	0.0%	1,602,974	6/30/2022
2022 Q1	5/13/2022	10,956	0.0%	1,613,505	3/31/2022
2021 Q4	2/14/2022	13,294	0.0%	1,592,032	12/31/2021
2021 Q3	11/12/2021	10,725	0.0%	1,443,429	9/30/2021
2021 Q2	8/13/2021	9,566	0.0%	1,406,825	6/30/2021
2021 Q1	5/14/2021	13,976	0.0%	1,360,765	3/31/2021
2020 Q4	2/12/2021	6,307	0.0%	901,060	12/31/2020
2020 Q3	11/16/2020	7,368	0.0%	902,992	9/30/2020
2020 Q2	8/14/2020	6,782	0.0%	982,863	6/30/2020
2020 Q1	5/15/2020	4,806	0.0%	1,011,825	3/31/2020
2019 Q4	2/14/2020	8,202	0.0%	939,538	12/31/2019